Bereavement Management - Description, Assessment and Care

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

402 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-06-30

Study Completion Date

2012-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to develop a risk assessment tool to identify bereaved in risk of complicated grief reactions and to implement a bereavement management programme in primary health care based on the Dual Process Model of coping with bereavement. Furthermore to enhance bereavement care in general practice and to enhance patients' self-management in bereavement care.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Aarhus Bereavement Study

NCT03049007

Grief

ACTIVE_NOT_RECRUITING

CONDOL01: Evaluation on the Experience of Bereavement, of a Medical Consultation, Proposed by a Letter of CONDOLence to the Patients' Relatives Versus Standard Practice After the Death of the Patient

NCT02861625

Caregivers

UNKNOWN

Systematic Support for Relatives of Palliative Care Patients

NCT05274841

Prolonged Grief Disorder

UNKNOWN NA

Group Therapy For Dementia Caregivers At Risk For Complicated Grief

NCT03177772

Grief

COMPLETED

Bereavement Support Program for Caregivers

NCT05826145

Bereavement

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In Denmark alone there are approximately 55.000 deaths annually which leave approximately 200.000 bereaved close relatives. International studies show that 10-15% of bereaved persons develop complications following the death of a close relative. If those studies hold true, approximately 20 - 30.000 individuals annually will develop complications as a result of suffering a loss, and there is hardly any knowledge of how bereavement is treated or even legitimized in primary care and referred on to specialized (psychological or psychiatric) care. The field of bereavement is in need of studies that validate the theoretical underpinnings of the research area, enhanced assessment of predictive risk factors and updated intervention methods: in short a scientifically valid management programme.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bereavement Grief

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention group

A) Professional level. B) Patient level.

Intervention

Professional level:

General Practitioners (GP) receive updated information on bereavement related symptoms, how to identify complicated grief, and the Dual Process Model (DPM) of coping.

GPs receive suggestions on how to provide psycho-educational support for the patient.

GPs are informed about the results of the initial assessment of their patient prognostic screening for complicated grief.

Patient level:

Patients receive updated information on bereavement related symptoms, the DPM of coping and suggestions on when to seek professional help.

Patients are informed of the results of their initial assessment of their prognostic grief screening.

Patients are encouraged to contact their GP if they worry about handling their bereavement reaction.

Group Type EXPERIMENTAL

Prognostic screening for complicated grief

Intervention Type OTHER

Patients in the intervention group are prognostically screened for development of complicated grief to identify those in need of help.

Control group

Treatment as usual (in the Danish health care system).

Group Type OTHER

Prognostic screening for complicated grief

Intervention Type OTHER

Patients in the intervention group are prognostically screened for development of complicated grief to identify those in need of help.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Prognostic screening for complicated grief

Patients in the intervention group are prognostically screened for development of complicated grief to identify those in need of help.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Newly bereaved from one of the inclusion facilities.
* 18 years or older.
* Danish citizen.
* Able to understand and speak Danish.
* Informed consent.
* Mentally able to cooperate

Exclusion Criteria

* Patients with known substance abuse.
* Patients with recently (within 5 years) diagnosed psychopathological disorders that trigger psychotic episodes.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No